GlaxoSmithKline PLC ’s Tres Cantos open lab has been fostering collaborative research into new medicines for diseases such as tuberculosis, malaria and Leishmaniasis for about three years and could move some molecules into clinical research as early as this year.
Scientists from around the world work at the lab, located outside Madrid, Spain, in collaboration with Glaxo drug discovery experts,...